Featured Research

from universities, journals, and other organizations

When parasites catch viruses: Viral symbiont of a protozoan parasite increases virulence to human host

Date:
November 7, 2012
Source:
Harvard Medical School
Summary:
A protozoan parasite causing an STD that affects a quarter of a billion people yearly is fueled in part by its own viral symbiont. Antibiotics that simply kill the parasite are not the solution.

Trichomona Vaginalis trophozoite.
Credit: Image courtesy of Centers for Disease Control and Prevention

When humans have parasites, the organisms live in our bodies, co-opt our resources and cause disease. However, it turns out that parasites themselves can have their own co-habitants.

Related Articles


Researchers from Harvard Medical School, Brigham and Women's Hospital and SUNY Upstate Medical University have found that the pathogenicity of the sexually transmitted protozoan parasite Trichomonas vaginalis -- the cause of trichomoniasis -- is fueled by a viral invader. Trichomoniasis infections are more common than all bacterial STDs combined. Annually, trichomoniasis affects nearly 250 million people, typically as vaginitis in women and urethritis in men.

"Trichomoniasis is associated with devastating consequences for women due to inflammation and related risks of reproductive disease," said Raina Fichorova, leader of the research team as well as associate professor of obstetrics, gynecology and reproductive biology at Brigham and Women's Hospital. "Our future goal is to determine how the viral symbiont and its inflammatory 'halo' affect the risk of preterm delivery and low birth weight."

"This is only one of two incidents that we know of for which the pathogenicity of a protozoan virus has been characterized," said Max Nibert, Harvard Medical School professor of microbiology and immunology and co-author of the paper. "When found together, the result is an increase in virulence of the protozoan parasite to the human host, leading to exacerbated disease."

This study, which was initiated by a Harvard Catalyst Pilot grant, will be published online in Public Library of Science (PLOS) One.

Rather than invading human cells, Trichomonas vaginalis attaches to their surface and feeds on them, sometimes remaining asymptomatic for a period of time. The virus, called Trichomonasvirus, infects the protozoan and increases its pathogenic power by fueling virus-specific inflammatory responses.

Moreover, carrying the protozoan parasite predisposes women to acquire sexually transmitted viruses, particularly HIV and human papillomavirus, or HPV, both of which can lead to serious diseases such as AIDS and cervical cancer, respectively. Fichorova and Nibert have recently obtained funding from the Harvard University Center for AIDS Research to find out if the virus itself is directly responsible for increased HIV risk.

According to Nibert, the virus-parasite symbiosis is the norm rather than the exception with this particular protozoan. Upwards of 80 percent of Trichomonas vaginalis isolates carry the virus. "Unlike flu viruses, for example, this virus can't spread by jumping out of the cell into another one," said Nibert, who has pioneered molecular biology work on double-stranded RNA viruses, a category that includes Trichomonasvirus. "It just spreads between cells when they divide or mate."

According to the researchers, it is this double-stranded nature of the viral genome that contributes to increased virulence of the protozoan parasite. "The double-stranded RNA seems important to the signaling process," added Nibert.

Currently, trichomoniasis is treated with the antibiotic metronidazole. But this treatment is only effective on the protozoan. "When the medication is used, the dying or stressed protozoa release unharmed virions, which then signal to the human cells," explained Fichorova. As a result, the symptoms are aggravated, and this in turn might increase the danger it poses to pregnant women and their children.

"Ahead is more research to better understand the viral cycle and structural features that might be vulnerable to drugs, which will lead to opening new doors for better treatment of trichomoniasis and related diseases," said Fichorova. "Our complementary expertise, interdisciplinary team efforts and strong collaboration is the key to our future success."

Nibert added that basic research on Trichomonas vaginalis is not nearly as supported as he thinks it should be. "It is unfortunate that a human pathogen of such worldwide significance has been neglected to such a degree," he said.


Story Source:

The above story is based on materials provided by Harvard Medical School. Note: Materials may be edited for content and length.


Journal Reference:

  1. Raina N. Fichorova, Yujin Lee, Hidemi S. Yamamoto, Yuko Takagi, Gary R. Hayes, Russell P. Goodman, Xenia Chepa-Lotrea, Olivia R. Buck, Ryan Murray, Tomasz Kula, David H. Beach, Bibhuti N. Singh, Max L. Nibert. Endobiont Viruses Sensed by the Human Host – Beyond Conventional Antiparasitic Therapy. PLoS ONE, 2012; 7 (11): e48418 DOI: 10.1371/journal.pone.0048418

Cite This Page:

Harvard Medical School. "When parasites catch viruses: Viral symbiont of a protozoan parasite increases virulence to human host." ScienceDaily. ScienceDaily, 7 November 2012. <www.sciencedaily.com/releases/2012/11/121107200024.htm>.
Harvard Medical School. (2012, November 7). When parasites catch viruses: Viral symbiont of a protozoan parasite increases virulence to human host. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2012/11/121107200024.htm
Harvard Medical School. "When parasites catch viruses: Viral symbiont of a protozoan parasite increases virulence to human host." ScienceDaily. www.sciencedaily.com/releases/2012/11/121107200024.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins